Establishment of primary patient‐derived xenografts of palliative TURP specimens to study castrate‐resistant prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|13|1475-1483

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.13, 2015-09, pp. : 1475-1483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Castrate-resistant prostate cancer: the right targets and combinations

By Karakunnel Joyson   Dahut William  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 57-61

Future Medicine

Access to resources Recommend Favorite

Castrate-Resistant Prostate Cancer with Peritoneal Metastases Treated with Docetaxel-Based Chemotherapy

By  

Urologia Internationalis, Vol. 93, Iss. 1, 2013-11 ,pp. : 49-54

Karger

Access to resources Recommend Favorite

Sequencing of Cabazitaxel in Metastatic Castrate-Resistant Prostate Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-06 ,pp. : 320-324

Karger

Access to resources Recommend Favorite

Very Fast Recovery of Acute Disseminated Intravascular Coagulation with Abiraterone Acetate in a Patient with Bone Metastases from Castrate-Resistant Prostate Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 625-627

Karger

Access to resources Recommend Favorite

Implementing newer agents for the management of CRPC

By  

BJU INTERNATIONAL, Vol. 115, Iss. 3, 2015-03 ,pp. : 364-372

John Wiley & Sons Inc

Access to resources Recommend Favorite